R&D Rare Disease Day: Enhancing clinical trial success in rare d... Rare diseases impact an estimated 300 million people globally, while around one in five cancers are considered a rare disease.
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.